Jiangxi Kvvit Pharmaceutical Co., Ltd.

This study tests a new cream called KR230109 for people with mild to moderate facial acne. About 180 adults aged 18 to 40 will use the cream or a placebo for 12 weeks. The goal is to see if the cream safely reduces pimples and skin bumps better than a placebo.

This early-stage study tests whether KR23248 capsules are safe and how the body processes them in 66 healthy adults aged 18 to 45. Participants receive either the drug or a placebo, and researchers monitor for side effects. This study does not aim to treat schizophrenia, only to …

This early-stage study tests a new drug, KR23343, in 92 healthy adults aged 18 to 45. The goal is to check if the drug is safe and how the body processes it, including the effect of food. Participants will receive either the drug or a placebo, and some will take it daily for 10 d…